Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy

NCT06218537 is registered in ClinicalTrials.gov with Carol Davila University of Medicine and Pharmacy as lead sponsor.

NCT NCT06218537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy
Lead sponsor
Carol Davila University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2024
Completion date
August 31, 2024
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper gastrointestinal endoscopy